Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
01/2006
01/04/2006EP1611139A1 Methods of preparing olanzapine
01/04/2006EP1611138A1 A novel crystalline form of dorzolamide hydrochloride
01/04/2006EP1611112A1 Isoxazole compounds as inhibitors of heat shock proteins
01/04/2006EP1294725B1 Multicyclic compounds and their use as inhibitors of parp, vegfr2 and mlk3 enzymes
01/04/2006EP1169298B1 Pharmaceutical compounds
01/04/2006CN1234712C 2-zminoalkyl-thieno [2, 3-D] pyrimidines
12/2005
12/29/2005WO2005123745A1 Tricyclic compounds
12/29/2005WO2005123744A1 Thienopyridone carboxamides and their medical use
12/29/2005WO2005123693A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors
12/29/2005WO2005123089A2 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease
12/29/2005US20050288376 Bicyclyl or heterobicyclylmethanesulfonylanimo-substituted N-hydroxyformamides
12/29/2005US20050288347 Certain triazole-based compounds, compositions, and uses thereof
12/29/2005US20050288331 Compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease
12/29/2005US20050288312 Bicyclic pyridine and pyrimidine p38 kinase inhibitors
12/29/2005US20050288294 N-ethyl-N'-{(3R)-1-[4-(3-phenylthieno[3,4-b]pyrazin-2-yl)benzyl]pyrrolidin-3-yl}urea; inhibit activity of a serine, threonine protein kinase; cancer
12/29/2005US20050288290 e.g. 1-(4-(6-Chloro-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-yloxy)-3-fluorophenyl)-3-(2-(4-fluorophenyl)acetyl)thiourea; mitogen-activated protein kinase inhibitor; anticarcinogenic agent, angiogenesis inhibitor; solid tumor, leukemia
12/29/2005US20050288285 Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
12/29/2005US20050288282 Anticancer agents; antiproliferative agents
12/29/2005US20050287594 Activity-based probes having specificity to the active form of enzymes and receptors; screening for desired biological activities or target proteins
12/29/2005CA2570196A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors
12/28/2005EP1609785A1 C-glycoside derivatives and salts thereof
12/28/2005EP1608631A2 Bi-cyclic pyrimidine inhibitors of tgf beta
12/28/2005EP1608626A1 Migrastatin analog compositions and uses thereof
12/28/2005EP1527076B1 Dihydro-dibenzo[b,e]oxepine based selective estrogen receptor modulators, compositions and methods
12/28/2005EP1224183B1 Heterocyclic sodium/proton exchange inhibitors and method
12/28/2005EP1084125B1 Condensed thienopyrimidines with phosphodiesterase-v inhibiting action
12/28/2005EP1031563B1 Sulfonyl derivatives
12/28/2005CN1714092A Thieno[3,2-b]pyridine-6-carbonitriles and thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors
12/28/2005CN1233646C Process of 2-methyl-thiophene benzodinitro heterotropilidene
12/27/2005US6979691 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/27/2005CA2189271C Novel erythromycin derivatives, method for their preparation and their use as drugs
12/22/2005WO2005121151A2 Thienopyridinone compounds and methods of treatment
12/22/2005WO2005121150A1 POLYMERISABLE THIENO[3,2-b]THIOPHENES
12/22/2005WO2005121138A2 Heterotricyclic compounds for use as hcv inhibitors
12/22/2005WO2005121125A1 Ether-linked heteroaryl compounds
12/22/2005WO2005120642A2 Tetrahydropyridothiophenes for treating hyperproliferative disorders
12/22/2005WO2005120186A2 Methyl 2,4,9-trithiaadamantane-7-carboxylate
12/22/2005US20050283007 adamanolol; 1'-(adamantane-1-carbonyl)-[4,4']bipiperidinyl-1-carboxylic acid [2-hydroxy-3-3-(1H-indol-4-yloxy)-propyl]-isopropyl-amide;human epidermal growth factor receptor antagonist; alpha-helix mimetics of Sur-2 (supressor of Ras); anticarcinogenic agent; breast cancer
12/22/2005US20050282863 Novel-N substituted dihydrobenzothiepino, dihydrobenzoxepino and tetrahydro benzocyclohepta indoles as selective estrogen receptor modulators
12/22/2005US20050282858 Substituted cycloalkylcarboxamides: 1-((1-(4-Chlorophenyl)cyclopropyl)carbonyl)pyrrolidin-3-ol and 1-Acetyl-4-(4-{1-[(3-phenylpyrrolidin-1-yl)carbonyl]cyclopropyl}phenyl)piperazine; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
12/22/2005US20050282852 Preventive and therapeutic medicament for gastroesophageal reflux disease
12/22/2005US20050282850 Tetrazolo[1,5-a]thieno[2,3-e]pyridine-4-carboxylic acid
12/22/2005US20050282848 Synthesis and use of tetracyclic benzamide derivatives; antidiabetic agents; coupling isochromene anhydride with cyanobenzene compound and performing ring substitution reactions
12/22/2005US20050282844 6,7-Dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
12/22/2005US20050282813 imidazo(1,5-a)-pyrazine-1,3-dione derivatives; Anticancer agents; immune disorders; (5S,8S,8aR)-4-[Octahydro-7-[(1,1-dimethylethoxy)carbonyl]-1,3-dioxo-5,8-methanoimidazo[1,5-a]pyrazin-2-yl]-2-(trifluoromethyl)benzonitrile
12/22/2005US20050282798 Pharmaceutical compounds
12/22/2005DE102004027332A1 New organometallic transition metal compound useful as catalyst constituents of catalyst systems for the polymerization of ethylene
12/22/2005CA2569623A1 Novel compounds and use of tetrahydropyridothiophenes
12/22/2005CA2567268A1 Thienopyridinone compounds and methods of treatment
12/21/2005EP1606255A2 Cyclic derivatives as modulators of chemokine receptor activity
12/21/2005EP1606254A1 2,4,6-phenyl substituted cyclic ketoenols
12/21/2005EP1606231A1 Process for preparation of clopidogrel, its salts and pharmaceutical compositions
12/21/2005EP1463728A4 Fused cyclic modulators of nuclear hormone receptor function
12/21/2005EP1458723A4 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function
12/21/2005EP1362039B1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
12/20/2005US6977263 Chemical compounds
12/20/2005CA2159481C Tetracyclic compounds as dopamine agonists
12/15/2005WO2005118654A1 Transition metal compound, ligand system, catalyst system and process for preparing polyolefins
12/15/2005WO2005118592A1 Tetrahydropyridothiophenes for use in the treatment of cancer
12/15/2005WO2005118543A1 Kinase inhibitor and use thereof
12/15/2005WO2005118071A2 Tetrahydropyridothiophenes
12/15/2005WO2005117907A2 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
12/15/2005WO2005117890A2 Thienopyrimidines and thiazolopyrimidines for use in medicine
12/15/2005WO2005117876A1 Dual small molecule inhibitors of cancer and angiogenesis
12/15/2005WO2005117866A1 Amorphous clopidogrel hydrochloride and its antithrombotic use
12/15/2005WO2005105065A3 Thiazole-based nitric oxide donors for treating inflammatory bowel diseases
12/15/2005US20050277658 Such as aurora-2 kinase or c-kit kinase; anticancer agents; based on benzo(4,5)furo(3,2-d)pyrimidine, 9-thia-1,5,7-triazafluorene, or pyrimido(5,4-b)indole rings; e.g. 6,7-dimethoxy-4-(4-(benzodioxol-5-ylmethylaminothiocarbonyl)-piperazin-1-yl)-5H-Pyrimido(5,4-b)indole
12/15/2005US20050277630 Antibacterial agents
12/15/2005US20050276754 Bridged aromatic substituted amine ligands with donor atoms
12/15/2005CA2568718A1 Tetrahydropyridothiophenes for use in the treatment of cancer
12/15/2005CA2568622A1 Dual small molecule inhibitors of cancer and angiogenesis
12/15/2005CA2567648A1 Novel tetrahydropyridothiophenes
12/14/2005EP1604979A1 2-oxo-1-pyrrolidine derivative and its pharmaceutical uses
12/14/2005EP1603921A1 Thiadibenzoazulene derivatives for the treatment of inflammatory diseases
12/14/2005EP1603920A1 Polymorph and amorphous form of (s)-(+)-clopidogrel bisulfate
12/14/2005EP1603914A1 Compounds having activity at 5ht2c receptor and uses thereof
12/14/2005EP1603881A2 Substituted thiophenes with antibacterial activity
12/14/2005EP1603571A2 Method for prognosticating the progress of breast cancer and compounds useful for prevention or treatment thereof
12/14/2005EP1603568A2 Isoquinoline derivatives and methods of use thereof
12/14/2005EP1603567A2 Tetracyclic benzamide derivatives and methods of use thereof
12/14/2005EP1043976B1 Oral pharmaceutical extended release dosage form
12/14/2005EP0865486B1 Stable biotinylated biomolecule composition and methods
12/14/2005CN1708493A Selected CGRP antagonists, method for production and use thereof as medicament
12/14/2005CN1708492A Selected CGRP antagonists, method for production and use thereof as medicament
12/14/2005CN1706848A Dithienyl trithiophene compound and its prepn and application
12/13/2005US6974870 Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
12/08/2005WO2004093805A3 Selective spirocyclic glucocorticoid receptor modulators
12/08/2005US20050272938 Cyclizing a 3-(carboxymethylamino)thiophene-2-carboxyaldehyde and deprotecting if necessary to form a 4H-thieno[3,2-b]pyrrole-5-carboxylic acid or ester; amidation
12/08/2005US20050272799 Fused Heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
12/08/2005US20050272762 Thienopyridines as IKK inhibitors
12/08/2005US20050272745 Novel piperidine and piperazine derivatives
12/08/2005US20050272736 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands
12/08/2005US20050272730 Thienopyridazines as IKK inhibitors
12/08/2005US20050272721 Stable salts of olanzapine
12/08/2005US20050272720 Process for making olanzapine Form I
12/08/2005US20050271673 Trifunctional reagent for conjugation to a biomolecule
12/07/2005EP1602658A1 Tricyclic pyrazole derivatives as cannabinoid receptor antagonists
12/07/2005EP1601673A1 Novel fused heterocycles and uses thereof
12/07/2005EP1246828B1 Benzosulfones with calcium antagonist activity
12/07/2005EP1171442B1 Xanthine derivatives and analogs as cell signalling inhibitors
1 ... 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 ... 214